Related Experiment Video
Updated: Aug 16, 2025

Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration
Published on: December 27, 2024
Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?
Laura El Nachef1, Elise Berthel1, Mélanie L Ferlazzo1
1Inserm, U1296 Unit, Radiation: Defense, Health and Environment, Centre Léon-Bérard, 69008 Lyon, France.
Abstract:
There are a number of genetic syndromes associated with both high cancer risk and clinical radiosensitivity. However, the link between these two notions remains unknown. Particularly, some cancer syndromes are caused by mutations in genes involved in DNA damage signaling and repair. How are the DNA sequence errors propagated and amplified to cause cell transformation? Conversely, some cancer syndromes are caused by mutations in genes involved in cell cycle checkpoint control. How is misrepaired DNA damage produced? Lastly, certain genes, considered as tumor suppressors, are not involved in DNA damage signaling and repair or in cell cycle checkpoint control. The mechanistic model based on radiation-induced nucleoshuttling of the ATM kinase (RIANS), a major actor of the response to ionizing radiation, may help in providing a unified explanation of the link between cancer proneness and radiosensitivity. In the frame of this model, a given protein may ensure its own specific function but may also play additional biological role(s) as an ATM phosphorylation substrate in cytoplasm. It appears that the mutated proteins that cause the major cancer and radiosensitivity syndromes are all ATM phosphorylation substrates, and they generally localize in the cytoplasm when mutated. The relevance of the RIANS model is discussed by considering different categories of the cancer syndromes.
Insights
Genetic syndromes link high cancer risk and radiosensitivity through ATM kinase. Mutations in ATM phosphorylation substrates, often cytoplasmic, explain this connection, unifying cancer proneness and radiation sensitivity.
Area of Science:
- Genetics
- Molecular Biology
- Radiation Oncology
Background:
- Genetic syndromes often present with both increased cancer risk and clinical radiosensitivity.
- The underlying molecular mechanisms connecting these two phenomena remain largely unknown.
- Mutations in DNA repair, signaling, or cell cycle control genes are implicated in various cancer syndromes.
Purpose of the Study:
- To explore a unified mechanistic model explaining the link between cancer proneness and radiosensitivity.
- To investigate the role of ATM kinase and its phosphorylation substrates in this context.
- To analyze how mutations affecting ATM substrates contribute to cancer and radiation sensitivity.
Main Methods:
- Review and discussion of the radiation-induced nucleoshuttling of ATM kinase (RIANS) model.
- Analysis of known cancer and radiosensitivity syndromes within the framework of the RIANS model.
- Examination of the subcellular localization and phosphorylation status of mutated proteins.
Main Results:
- The RIANS model provides a potential unified explanation for the co-occurrence of cancer proneness and radiosensitivity.
- Mutated proteins responsible for major cancer and radiosensitivity syndromes are identified as ATM phosphorylation substrates.
- These mutated proteins frequently exhibit cytoplasmic localization.
Conclusions:
- The RIANS model offers a framework to understand how mutations in ATM substrates contribute to both cancer development and cellular radiosensitivity.
- Cytoplasmic localization of mutated ATM substrates may be a key factor in these syndromes.
- Further investigation into the RIANS model could elucidate the interplay between DNA damage response and cancer predisposition.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
13:10Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Inhibition of Cdk Activity
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...